Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Hurle

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 7, 2010
Inhibition of p38 mitogen-activated protein kinase reduces inflammation after coronary vascular injury in humansLea Sarov-Blat, John M Morgan, Pedro Fernandez, et al.
Plos One|April 20, 2019
Preclinical evaluation of EPHX2 inhibition as a novel treatment for inflammatory bowel diseaseWilliam C Reisdorf, Qing Xie, Xin Zeng, et al.
Nature Genetics|September 8, 2020
Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseasesJie Zheng, Valeriia Haberland, Denis Baird, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 7, 2010
Inhibition of p38 mitogen-activated protein kinase reduces inflammation after coronary vascular injury in humansLea Sarov-Blat, John M Morgan, Pedro Fernandez, et al.
Plos One|April 20, 2019
Preclinical evaluation of EPHX2 inhibition as a novel treatment for inflammatory bowel diseaseWilliam C Reisdorf, Qing Xie, Xin Zeng, et al.
Nature Genetics|September 8, 2020
Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseasesJie Zheng, Valeriia Haberland, Denis Baird, et al.
Pageof 2